All lobbying filings

DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.)

DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.) filed a Q1 report for DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.) on April 21, 2025.

Lobbying for DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.) · Biopharmaceutical organization developing medicines for disorders of the brain.

All filings by DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.) · Everything DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.) has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 21, 2025

Expenses

$100,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Maryland

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Mental Health, FDA/DEA communication on controlled substances, VA funding for operational infrastructure for mental health care

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.